Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, June 18, 2024
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
Jeff Jones Reiterated (catx) at Buy with Increased Target to $19 on, Jun 18th, 2024
Jeff Jones of Oppenheimer, Reiterated "Perspective Therapeutics, Inc." (CATX) at Buy with Increased Target from $2 to $19 on, Jun 18th, 2024.
Jeff has made no other calls on CATX in the last 4 months.
There are 3 other peers that have a rating on CATX. Out of the 3 peers that are also analyzing CATX, 0 agree with Jeff's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Jeff
- Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $30 on, Friday, June 14th, 2024
- Justin Walsh of "Jones Trading" Maintained at Strong Buy with Increased Target to $22 on, Thursday, May 16th, 2024
- Yuan Zhi of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $17 on, Tuesday, April 9th, 2024
